Ro, a New York-based direct-to-patient healthcare company, announced on Wednesday that it has added obesity research expert David B Allison to its Advisory Board.

In the new role, Allison is to support the company's research and educational initiatives.

Allison, an award-winning obesity researcher and biostatistician, is acting as an independent consultant for Ro, and not on behalf of or representing any institution. He works as dean and distinguished professor at the Indiana University School of Public Health-Bloomington. He has authored over 700 scientific publications concentrated on obesity as a disease, nutrition, aging and longevity.

Melynda Barnes, MD, Ro chief medical officer, said, 'At an exciting time of rapid advancement in the science and practice of obesity medicine, each of our advisors is at the forefront of their fields, driving critical innovation in obesity care. I look forward to continuing to work with our Advisory Board members to use their combined expertise to build a new paradigm for patient-centric care at Ro.'